Thiotepa 25021-0246-02

Package NDC

25021-0246-02

Manufacturer: Sagent Pharmaceuticals
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intracavitary, Intravenous, And Intravesical
Product Type: Human Prescription Drug
Marketing Start: June 15, 2018
Listing Expires: December 31, 2026
Application: ANDA209150

Need to source Thiotepa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Thiotepa	15 mg/1.5mL

Drug Class

Alkylating Drug [EPC]Alkylating Activity [MoA]Alkylating Drug [EPC]

Selected Package

25021-0246-02Selected

1 VIAL in 1 CARTON (25021-246-02) / 1.5 mL in 1 VIAL